A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer (Q35987286)

11 August 2017

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer (English)

1 reference

11 August 2017

50

Jean-Yves Blay

0 references

Alexander Eggermont

52

Alexander Eggermont

0 references

Jean-Charles Soria

55

Jean-Charles Soria

0 references

Jean-Yves Scoazec

57

Jean-Yves Scoazec

0 references

Razelle Kurzrock

59

Razelle Kurzrock

1 reference

11 August 2017

25

Thierry Le Chevalier

1 reference

11 August 2017

Dr. Bianca Lins, LL.M.

17

Amir Onn

1 reference

11 August 2017

4

Yudi Pawitan

1 reference

11 August 2017

1

Vladimir Lazar

1 reference

11 August 2017

Ioana Berindan-Neagoe

31

Ioana Berindan-Neagoe

1 reference

11 August 2017

34

Alexandru Irimie

1 reference

11 August 2017

20

Angel Porgador

1 reference

11 August 2017

58

Waun Ki Hong

1 reference

11 August 2017

Eitan Rubin

2

1 reference

11 August 2017

Stephane Depil

3

1 reference

11 August 2017

Jean-François Martini

5

1 reference

11 August 2017

Jesus Gomez-Navarro

6

1 reference

11 August 2017

Antoine Yver

7

1 reference

11 August 2017

Zhengyin Kan

8

1 reference

11 August 2017

Jonathan R Dry

9

1 reference

11 August 2017

Jeanne Kehren

10

1 reference

11 August 2017

Pierre Validire

11

1 reference

11 August 2017

Jordi Rodon

12

1 reference

11 August 2017

Philippe Vielh

13

1 reference

11 August 2017

Michel Ducreux

14

1 reference

11 August 2017

Susan Galbraith

15

1 reference

11 August 2017

Manfred Lehnert

16

1 reference

11 August 2017

Raanan Berger

18

1 reference

11 August 2017

Marco A Pierotti

19

1 reference

11 August 2017

C S Pramesh

21

1 reference

11 August 2017

Ding-wei Ye

22

1 reference

11 August 2017

Andre L Carvalho

23

1 reference

11 August 2017

Gerald Batist

24

1 reference

11 August 2017

Philippe Morice

26

1 reference

11 August 2017

Benjamin Besse

27

1 reference

11 August 2017

Gilles Vassal

28

1 reference

11 August 2017

Andrew Mortlock

29

1 reference

11 August 2017

Johan Hansson

30

1 reference

11 August 2017

Robert Dann

32

1 reference

11 August 2017

Joel Haspel

33

1 reference

11 August 2017

Steve Laderman

35

1 reference

11 August 2017

Hovav Nechushtan

36

1 reference

11 August 2017

Amal S Al Omari

37

1 reference

11 August 2017

Trent Haywood

38

1 reference

11 August 2017

Catherine Bresson

39

1 reference

11 August 2017

Khee Chee Soo

40

1 reference

11 August 2017

Iman Osman

41

1 reference

11 August 2017

Hilario Mata

42

1 reference

11 August 2017

Jack J Lee

43

1 reference

11 August 2017

Komal Jhaveri

44

1 reference

11 August 2017

Guillaume Meurice

45

1 reference

11 August 2017

Gary Palmer

46

1 reference

11 August 2017

Ludovic Lacroix

47

1 reference

11 August 2017

Serge Koscielny

48

1 reference

11 August 2017

Karina Agda Eterovic

49

1 reference

11 August 2017

Richard Buller

51

1 reference

11 August 2017

Richard L Schilsky

53

1 reference

11 August 2017

John Mendelsohn

54

1 reference

11 August 2017

Mace Rothenberg

56

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

14139-14152

1 reference

11 August 2017

16

1 reference

Comprehensive molecular profiling of lung adenocarcinoma

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Principles and methods of integrative genomic analyses in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

2 October 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Integrated molecular portrait of non-small cell lung cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Molecular profiling and the reclassification of cancer: divide and conquer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

2 October 2017

Cancer genome landscapes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Hallmarks of Cancer: The Next Generation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Circular binary segmentation for the analysis of array-based DNA copy number data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Expression profiling--best practices for data generation and interpretation in clinical trials.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546456

Why most gene expression signatures of tumors have not been useful in the clinic

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25944621

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.3741

0 references

1 reference

11 August 2017

1 reference